Inogen (INGN) Income from Continuing Operations (2013 - 2026)

Inogen's (INGN) quarterly Income from Continuing Operations came in at 8324000.0 in Q1 2026, down 34.82% year-on-year from 12771465.21 in Q1 2025, and down 193.39% on a QoQ basis from 8913000.0 in Q4 2025.

Inogen (INGN) Income from Continuing Operations (2013 - 2026) Analysis & Trends

Inogen (INGN) has 14 years of Income from Continuing Operations data on file, last reported at 8324000.0 in Q1 2026.

  • On a quarterly basis, Income from Continuing Operations fell 34.82% year-over-year to 8324000.0 in Q1 2026; TTM through Mar 2026 was 8857000.0, a 58.14% increase from a year earlier, with the FY2025 full-year figure at 6707000.0, up 77.31% from the prior year.
  • Income from Continuing Operations for Q1 2026 stood at 8324000.0, down from 8913000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for INGN reached as high as 72460000.0 in Q4 2023 and fell as low as 56610000.0 in Q4 2022.
  • Historically, Income from Continuing Operations has averaged 7753058.82 across 5 years, with a median of 6174000.0 in 2025.
  • Across the five-year window, Income from Continuing Operations slumped 1841.8% in 2022 and soared 359.55% in 2025, its largest moves.
  • Year by year, Income from Continuing Operations stood at 56610000.0 in 2022, then jumped by 228.0% to 72460000.0 in 2023, then tumbled by 104.74% to 3434000.0 in 2024, then surged by 359.55% to 8913000.0 in 2025, then plunged by 193.39% to 8324000.0 in 2026.
  • Per Business Quant data, the three most recent Income from Continuing Operations figures were 8324000.0 in Q1 2026, 8913000.0 in Q4 2025, and 5294000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 1.08 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 745.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 380.70 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 199.50 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 273.95 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 411.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Inogen 172.68 Mn 62.51 Mn 37.86 Mn -8.32 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -8.32 Mn
Dec 31, 2025 8.91 Mn
Sep 30, 2025 -5.29 Mn
Jun 30, 2025 -4.15 Mn
Mar 31, 2025 -6.17 Mn
Dec 31, 2024 -3.43 Mn
Sep 30, 2024 -5.96 Mn
Jun 30, 2024 -5.59 Mn
Mar 31, 2024 -14.58 Mn
Dec 31, 2023 72.46 Mn
Sep 30, 2023 -45.72 Mn
Jun 30, 2023 -9.83 Mn
Mar 31, 2023 -20.35 Mn
Dec 31, 2022 -56.61 Mn
Sep 30, 2022 -9.51 Mn
Jun 30, 2022 -3.44 Mn
Mar 31, 2022 -14.21 Mn
Dec 31, 2021 -22.88 Mn
Sep 30, 2021 12.17 Mn
Jun 30, 2021 5.10 Mn